¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) KSC 2020 (´ëÇѽÉÀåÇÐȸ Á¦64Â÷ Ãß°èÇмú´ëȸ) 1ÀÏÂ÷ : 2020-10-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) KSC 2020 (´ëÇѽÉÀåÇÐȸ Á¦64Â÷ Ãß°èÇмú´ëȸ) 1ÀÏÂ÷ : 2020-10-16
±³À°ÀÏÀÚ : 2020-10-16
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À° (½Ç½Ã°£ È­»ó °­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) KSC 2020 (´ëÇѽÉÀåÇÐȸ Á¦64Â÷ Ãß°èÇмú´ëȸ) 1ÀÏÂ÷      
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ  
¿¬¶ôó : 02-3275-5258  
À̸ÞÀÏ : herz8@circulation.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í ±³¼ö ¹× °³¿øÀÇ-20000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-10000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ08:40~08:52 Pro: Swan-Ganz Catheter in Cardiac Critical Care: It Should Be Done in Some Cases  ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ08:52~09:04 Con: Echocardiographic Hemodynamic Monitoring Is Enough  ±è¹Ì³ª(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ09:04~09:09 Pro Rebuttal  ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ09:09~09:14 Con Rebuttal  ±è¹Ì³ª(°í·ÁÀÇ´ë) 
Åä·Ð 10¿ù 16ÀÏ ¿Â¶óÀΠ09:14~09:25 Discussion  () 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ09:25~09:37 Pro: Awake ECMO, Pros  À̼ö¿ë(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ09:37~09:49 Con: Awake ECMO, Cons  À̼±±â(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ09:49~09:54 Pro Rebuttal  À̼ö¿ë(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ09:54~09:59 Con Rebuttal  À̼±±â(ÇѸ²ÀÇ´ë) 
Åä·Ð 10¿ù 16ÀÏ ¿Â¶óÀΠ09:59~10:10 Discussion  () 
È޽Ġ10¿ù 16ÀÏ  10:10~10:20 Break  () 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ10:20~10:30 The Trend and Burden of Korean AF  ¾çÇʼº(Â÷ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ10:30~10:40 Risk Stratification of Thromboembolism  À̱¤³ë(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ10:40~10:50 Imaging Modalities for AF Treatment  ÀÌÁ¤¸í(°æÈñÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ10:50~11:00 Korean Practical Guideline of NOAC Use  ¹ÚÁø±Ô(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ11:00~11:10 Selection of NOAC  À̼ҷÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ11:10~11:20 Wearable Monitoring and Opportunistic Screening of AF: State of the Art  ¹é¿ë¼ö(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ11:20~11:30 How to Apply Korean Anticoagulation Guideline in PCI Patients  È²À¯¹Ì(°¡Å縮ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ11:30~11:40 Non-genetic Risk Factor for AF  ±èÀ±±â(°í·ÁÀÇ´ë) 
Åä·Ð 10¿ù 16ÀÏ  11:40~11:50 Discussion  () 
È޽Ġ10¿ù 16ÀÏ  11:50~12:00 Break  () 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ12:00~12:20 The evolution of the ESC atrial fibrillation management guideline  ½Å½Â¿ë(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ12:20~12:40 Antithrombotic therapy in patients with NVAF undergoing PCI : Would you choose Eliquis?  ³²Ã¢¿í(°è¸íÀÇ´ë) 
È޽Ġ10¿ù 16ÀÏ  12:40~14:00 Break  () 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ14:00~14:10 Introduction- Incidence Epidemiology Risk   ¾çÇʼº(Â÷ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ14:10~14:20 AF Causing HF Versus HF Causing AF: Can We Tell One the Other  ±èÀÀÁÖ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ14:20~14:30 Optimal Management of the Patients with AF and HF: Anticoagulation and Antiarrhythmic Drugs  ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ14:30~14:40 Optimal Management of the Patients with AF and HF: Beta-blocker Still Useful?  ¹ÚÁøÁÖ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ14:40~14:50 Role of AF Ablation in HF - AF Ablation vs. AV Node Ablation and CRT as Primary Therapy  ¹ÚÇü¼·(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ14:50~15:00 AF in HF: Ablate or Not?  ÀÌ»ó¾ð(¿ï»êÀÇ´ë) 
Åä·Ð 10¿ù 16ÀÏ ¿Â¶óÀΠ15:00~15:30 Discussion  () 
È޽Ġ10¿ù 16ÀÏ  15:30~15:40 Break  () 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ15:40~16:00 Embryology of Conduction System  ±èÁ¤¼±(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ16:00~16:20 His-purkinje System  ¿ÀÀÏ¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ16:20~16:40 Cardiac Conduction System in Congenital Heart Disease  S Yen Ho(Royal Brompton Hospital UK) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ16:40~17:00 Cardiac Conduction System for Electrophysiologist  S Yen Ho(Royal Brompton Hospital UK) 
Åä·Ð 10¿ù 16ÀÏ  17:00~17:10 Discussion  () 
È޽Ġ10¿ù 16ÀÏ  17:10~17:20 Break  () 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ17:20~17:35 Remote Monitoring by Implantable Devices  Á¤º¸¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ17:35~17:50 Remote Monitoring by Wearable Devices  ¿ÀÀÏ¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ17:50~18:05 Ubiquitous Blood Pressure Monitoring by New Technologies  ¹ÚÁغó(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀΠ18:05~18:20 Pro and Cons of Telemonitoring of ICU  Àü±âÇö(¸ÞµðÇ÷º½º¼¼Á¾º´¿ø) 
Åä·Ð 10¿ù 16ÀÏ  18:20~18:50 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) KSC 2020 (´ëÇѽÉÀåÇÐȸ Á¦64Â÷ Ãß°èÇмú´ëȸ) 1ÀÏÂ÷ : 2020-10-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) Á¦70ȸ ´ëÇÑÇغÎÇÐȸ Á¤±â Çмú´ëȸ : 2020-10-16
´ÙÀ½±Û 2020 ´ëÇѼºÇü¿Ü°úÇÐȸ ±¤ÁÖÀü³²Áöȸ Ãß°èÇÐȸ : 2020-10-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 6 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 4 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 3 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 3 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 4 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 3 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 0 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 0 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 0 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 2 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 0 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 0 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 2 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 1 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 1 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷